AGL / agilon health, inc. (AGL) CEO Steven Sell on Q1 2022 Results - Earnings Call Transcript

Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2023, it might be worth consid more_horizontal

agilon health expects positive adjusted EBITDA in 2023 and is experiencing double-digit net sales growth. The company's growth is driven by an increas more_horizontal

agilon health, inc. (NYSE:AGL ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Matthew Gillmor - Vice President, Inve more_horizontal

While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2023, it could be worth l more_horizontal

Agilon Health (AGL) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of more_horizontal

agilon health has achieved its first quarter with over $1 billion in revenues, largely due to significant membership growth. AGL is taking strong step more_horizontal

These are the growth stocks with the fastest EPS and revenue growth heading into June. more_horizontal

agilon health, inc. (NYSE:AGL ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO more_horizontal